Charles Schwab Investment Management Inc Immunic, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Immunic, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 25,100 shares of IMUX stock, worth $29,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,100
Previous 25,000
0.4%
Holding current value
$29,618
Previous $33,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMUX
# of Institutions
67Shares Held
56MCall Options Held
4.7KPut Options Held
311K-
Avidity Partners Management LP Dallas, TX8.9MShares$10.5 Million0.49% of portfolio
-
Bvf Inc San Francisco, CA8.9MShares$10.5 Million0.3% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$8.61 Million0.82% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$8.35 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$6.6 Million0.01% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $36.1M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...